Decopharma has been acquired by CTT
Decopharma has been acquired by CTT – Correios de Portugal, strengthening its position as a national reference in pharmaceutical logistics solutions. This strategic transaction marks an important step in the consolidation of the specialized logistics sector in Portugal, combining Decopharma’s expertise in healthcare logistics with CTT’s robust infrastructure and growth potential.
Decopharma provides end-to-end logistics services for the pharmaceutical and healthcare sectors, covering medicines such as over-the-counter products (OTC), nutraceuticals, cosmetics and veterinary items, as well as medical devices including hospital equipment, consumables and laboratory supplies. With a team of around 30 employees, the company manages the entire logistics chain — from goods reception and storage to quality control, order processing and distribution.
CTT – Correios de Portugal is a leading provider of integrated logistics and distribution services, offering parcel delivery, express shipping and e-commerce solutions. Backed by a nationwide infrastructure and specialized subsidiaries like CTT Expresso, the company enables efficient last-mile delivery and supply chain operations for businesses across various sectors.
Oaklins’ team in Portugal advised the shareholders of Decopharma in this transaction.
Contáctese con el equipo de la transacción
Transacciones relacionadas
EuroHospital Varna has been acquired by Intermedica Group
EuroHospital Varna has been acquired by Intermedica Group, allowing the business to continue to grow and deliver high-quality healthcare services to its patients. Through the transaction, Intermedica Group expands its healthcare presence and intends to build a new model of integrated personalized care focused on preventive, holistic and digital medicine.
Ver másMEDIK Hospital Design Group has been acquired by STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.
Ver másbioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Rancoderm GmbH has been acquired by Rose Investment- und Beteiligungs AG to secure the funding required for the final development and market approval of its medical device DermaPro. The acquisition will enable Rancoderm to bring DermaPro to market readiness and launch it as a certified medical product for broad distribution.
Ver más